USE OF 2-[18F]FLUORO-2-DEOXYGLUCOSE AS A POTENTIAL AGENT IN THE PREDICTION OF GRAFT REJECTION BY POSITRON EMISSION TOMOGRAPHY1

    loading  Checking for direct PDF access through Ovid

Abstract

Background.

We investigated the potential of predicting allograft rejection by measuring the ability of graft-infiltrating cells to take up 2-[18F]fluoro-2-deoxyglucose ([18F]FDG). This molecule is a positron emitting glucose analogue that is taken up by metabolically active cells and can be detected using positron emission tomography.

Methods.

Uptake of [18F]FDG during an alloresponse was measured both in vitro in mixed lymphocyte cultures and in vivo using allogeneic and syngeneic skin grafts.

Results.

Uptake of [18F]FDG was seen in a mixed lymphocyte reaction. Using a mouse skin graft model, we found that mean [18F]FDG uptake was 1.5-2 times higher in allografts than in syngeneic grafts; the increase in uptake correlated with the level of T-cell infiltrate seen histologically.

Conclusion.

Assessing the metabolic activity of graft-infiltrating cells with [18F]FDG may be useful in the prediction of graft rejection episodes.

Related Topics

    loading  Loading Related Articles